Decoy Therapeutics is trading 9.67% up at $2.95 after closing at $2.67 on September 11, 2026; no confirmed company-specific announcement or earnings release explaining the pre-market move was found.
- A special shareholder meeting is scheduled for September 14, 2026, to vote on warrant exercises, authorized-share reduction, and possible adjournment; its connection to the gain is unconfirmed.
- Broader markets are weaker, so global sentiment does not explain the gain.